339 related articles for article (PubMed ID: 30871574)
1. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
2. The use of nutraceutics in children's and adolescent's headache.
Sangermani R; Boncimino A
Neurol Sci; 2017 May; 38(Suppl 1):121-124. PubMed ID: 28527085
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
4. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
Shrivastava R; Pechadre JC; John GW
Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of nutraceuticals in migraine prophylaxis.
D'Onofrio F; Raimo S; Spitaleri D; Casucci G; Bussone G
Neurol Sci; 2017 May; 38(Suppl 1):117-120. PubMed ID: 28527067
[TBL] [Abstract][Full Text] [Related]
6. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
7. Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.
Orr SL; Venkateswaran S
Cephalalgia; 2014 Jul; 34(8):568-83. PubMed ID: 24443395
[TBL] [Abstract][Full Text] [Related]
8. Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.
Carotenuto M; Esposito M
Neurol Sci; 2013 Nov; 34(11):1905-9. PubMed ID: 23532548
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
Das R; Qubty W
Pediatr Neurol; 2021 Jan; 114():5-8. PubMed ID: 33189027
[TBL] [Abstract][Full Text] [Related]
10. Migraine and tension headache--a complementary and alternative medicine approach.
Woolhouse M
Aust Fam Physician; 2005 Aug; 34(8):647-51. PubMed ID: 16113701
[TBL] [Abstract][Full Text] [Related]
11. "Natural" or alternative medications for migraine prevention.
Evans RW; Taylor FR
Headache; 2006 Jun; 46(6):1012-8. PubMed ID: 16732849
[No Abstract] [Full Text] [Related]
12. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study.
Esposito M; Carotenuto M
Neurol Sci; 2011 Feb; 32(1):79-81. PubMed ID: 20872034
[TBL] [Abstract][Full Text] [Related]
13. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
Gaul C; Diener HC; Danesch U;
J Headache Pain; 2015; 16():516. PubMed ID: 25916335
[TBL] [Abstract][Full Text] [Related]
14. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
Bruijn J; Duivenvoorden H; Passchier J; Locher H; Dijkstra N; Arts WF
Cephalalgia; 2010 Dec; 30(12):1426-34. PubMed ID: 20974610
[TBL] [Abstract][Full Text] [Related]
15. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Maizels M; Blumenfeld A; Burchette R
Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
[TBL] [Abstract][Full Text] [Related]
16. Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience.
Vernieri F; Paolucci M; Altamura C; Pasqualetti P; Mastrangelo V; Pierangeli G; Cevoli S; D'Amico D; Grazzi L
Headache; 2019 Sep; 59(8):1300-1309. PubMed ID: 31454075
[TBL] [Abstract][Full Text] [Related]
17. Nutraceuticals and migraine: further strategy for the treatment of specific conditions.
Quintana S; Russo M; Torelli P
Neurol Sci; 2022 Nov; 43(11):6565-6567. PubMed ID: 35792970
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of integrative therapies for prevention and treatment of migraine headaches.
Ross SM
Holist Nurs Pract; 2011; 25(1):49-52. PubMed ID: 21150505
[No Abstract] [Full Text] [Related]
19. Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine.
Yamanaka G; Suzuki S; Takeshita M; Go S; Morishita N; Takamatsu T; Daida A; Morichi S; Ishida Y; Oana S; Nara S; Shimura M; Nishimata S; Kawashima H
Brain Dev; 2020 Aug; 42(7):523-528. PubMed ID: 32336482
[TBL] [Abstract][Full Text] [Related]
20. Use of aspirin combinations with caffeine and increasing headache frequency: a prospective population-based study.
Schramm SH; Moebus S; Özyurt Kugumcu M; Geisel MH; Obermann M; Yoon MS; Diener HC; Jöckel KH; Katsarava Z
Pain; 2015 Sep; 156(9):1747-1754. PubMed ID: 26010457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
